Home
>
US Stocks
>
Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
AKBA

Akebia Therapeutics Inc.

$2.859.2%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
2.94
Today Low/High
2.84 / 2.94
52 Week Low/High
$2.09 / $11.26
Market Cap
$446.82M

Company Details

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts.
Organisation
Akebia Therapeutics Inc.
Headquaters
Cambridge, Massachusetts, US
Employees
380
Industry
Health Technology
CEO
John Butler

Discover more

Frequently Asked Questions

What is Akebia Therapeutics Inc. share price today

Can Indians buy Akebia Therapeutics Inc. shares?

How can I buy Akebia Therapeutics Inc. shares from India?

Can Fractional shares of Akebia Therapeutics Inc. be purchased?

What are the documents required to start investing in Akebia Therapeutics Inc. stocks?

We are a SEBI registered investement advisor